➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Merck
AstraZeneca
McKinsey
Medtronic

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for ASP0456


Email this page to a colleague

« Back to Dashboard

What is the drug development status for ASP0456?

ASP0456 is an investigational drug.

There have been 6 clinical trials for ASP0456. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2016.

The most common disease conditions in clinical trials are Constipation, Irritable Bowel Syndrome, and Syndrome. The leading clinical trial sponsors are Astellas Pharma Inc and [disabled in preview].

There are two hundred and twenty-eight US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for ASP0456
TitleSponsorPhase
A Study of Oral Dosing of ASP0456 in Patients With Chronic ConstipationAstellas Pharma IncPhase 3
A Study to Evaluate Dose-responses of Efficacy and Safety of ASP0456 in Patient With Chronic ConstipationAstellas Pharma IncPhase 2
Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel SyndromeAstellas Pharma IncPhase 3

See all ASP0456 clinical trials

Clinical Trial Summary for ASP0456

Top disease conditions for ASP0456
Top clinical trial sponsors for ASP0456

See all ASP0456 clinical trials

US Patents for ASP0456

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ASP0456   Get Started Free Ultra-pure agonists of guanylate cyclase C, method of making and using same SYNERGY PHARMACEUTICALS, INC. (New York, NY)   Get Started Free
ASP0456   Get Started Free Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide Alkermes, Inc. (Waltham, MA)   Get Started Free
ASP0456   Get Started Free Formulations of guanylate cyclase C agonists and methods of use SYNERGY PHARMACEUTICALS, INC. (New York, NY)   Get Started Free
ASP0456   Get Started Free Benzazole compounds and methods for making and using the compounds Rigel Pharmaceuticals, Inc. (South San Francisco, CA)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for ASP0456

Drugname Country Document Number Estimated Expiration Related US Patent
ASP0456 Australia AU2014274812 2033-06-05   Get Started Free
ASP0456 Australia AU2018226473 2033-06-05   Get Started Free
ASP0456 Australia AU2020205349 2033-06-05   Get Started Free
ASP0456 Canada CA2913737 2033-06-05   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Johnson and Johnson
Express Scripts
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.